BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1763412)

  • 1. Renal accumulation and urinary excretion of cisplatin in diabetic rats.
    Valentovic MA; Scott LA; Madan E; Yokel RA
    Toxicology; 1991; 70(2):151-62. PubMed ID: 1763412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of streptozotocin (STZ)-induced diabetes, dextrose diuresis and acetone on cisplatin nephrotoxicity in Fischer 344 (F344) rats.
    Scott LA; Madan E; Valentovic MA
    Toxicology; 1990; 60(1-2):109-25. PubMed ID: 2107603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of cisplatin nephrotoxicity by streptozotocin-induced diabetes.
    Scott LA; Madan E; Valentovic MA
    Fundam Appl Toxicol; 1989 Apr; 12(3):530-9. PubMed ID: 2731667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cephaloridine renal accumulation and urinary excretion between normoglycemic and diabetic animals.
    Valentovic MA; Ball JG; Rogers BA
    Toxicology; 1996 Apr; 108(1-2):93-9. PubMed ID: 8644123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced renal accumulation and toxicity of cisplatin in experimental galactosemia.
    Cacini W; Harden EA; Skau KA
    Proc Soc Exp Biol Med; 1993 Jul; 203(3):348-53. PubMed ID: 8516346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cephaloridine nephrotoxicity in streptozotocin induced diabetic Fischer 344 (F344) rats.
    Valentovic MA; Ball JG; Elliott C; Madan E
    Toxicology; 1989 Jul; 57(2):193-207. PubMed ID: 2749746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of route of administration and dose on diabetes-induced protection against cisplatin nephrotoxicity.
    Sarangarajan R; Cacini W
    Proc Soc Exp Biol Med; 1996 Sep; 212(4):362-8. PubMed ID: 8751995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of acetone and osmotic-diuresis by streptozotocin-induced diabetes in attenuation of cephaloridine nephrotoxicity.
    Valentovic M; Ball JG; Anestis D
    Toxicology; 1992; 71(3):245-55. PubMed ID: 1736416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the diuretics mannitol or acetazolamide on nephrotoxicity and physiological disposition of cisplatin in rats.
    Osman NM; Copley MP; Litterst CL
    Cancer Chemother Pharmacol; 1984; 13(1):58-62. PubMed ID: 6428763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between increased atrial natriuretic peptide and reduced cisplatin nephrotoxicity in rats.
    Ormond PM; Basinger MA; Jones MM; Hande KR
    J Pharmacol Exp Ther; 1992 Jul; 262(1):246-51. PubMed ID: 1385629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-(3,5-dichlorophenyl)succinimide nephrotoxicity in streptozotocin-induced diabetic rats.
    Valentovic MA; Teets VJ; Nicoll D; Stern J; Leppla D; Rankin GO
    Toxicology; 1990 Sep; 63(3):327-39. PubMed ID: 2145659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early onset of cisplatin-induced nephrotoxicity in streptozotocin-diabetic rats treated with insulin.
    Sarangarajan R; Cacini W
    Basic Clin Pharmacol Toxicol; 2004 Aug; 95(2):66-71. PubMed ID: 15379782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal metallothionein and platinum levels in diabetic and nondiabetic rats injected with cisplatin.
    Cacini W; Singh Y
    Proc Soc Exp Biol Med; 1991 Jul; 197(3):285-9. PubMed ID: 2068122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cephaloridine nephrotoxicity in diabetic rats: modulation by insulin treatment.
    Valentovic MA; Ball JG
    Toxicology; 1995 Jun; 100(1-3):11-6. PubMed ID: 7624867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normalization of hyperglycaemia by oral vanadyl sulfate does not reverse diabetes-induced protection against cisplatin nephrotoxicity in streptozotocin-diabetic rats.
    Sarangarajan R; Cacini W
    Pharmacol Toxicol; 1999 Oct; 85(4):169-73. PubMed ID: 10563515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin pharmacokinetics and its nephrotoxicity in diabetic rabbits.
    Najjar TA; Saad SY
    Chemotherapy; 2001; 47(2):128-35. PubMed ID: 11173815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interactions of cis-diamminedichloroplatinum with metallothionein and glutathione in rat liver and kidney.
    Suzuki CA; Cherian MG
    Toxicology; 1990 Nov; 64(2):113-27. PubMed ID: 1977210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of platinum levels in plasma, urine, and kidney on blood urea nitrogen levels after cisplatin injection in rats.
    Uozumi J; Litterst CL
    J Pharmacobiodyn; 1988 Apr; 11(4):277-83. PubMed ID: 3411443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of cisplatin-induced nephrotoxicity by the diuretic acetazolamide in F344 rats.
    Osman NM; Copley MP; Litterst CL
    Cancer Treat Rep; 1984; 68(7-8):999-1004. PubMed ID: 6540145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of octreotide and insulin on manifest renal and glomerular hypertrophy and urinary albumin excretion in long-term experimental diabetes in rats.
    Grønbaek H; Nielsen B; Osterby R; Harris A; Orskov H; Flyvbjerg A
    Diabetologia; 1995 Feb; 38(2):135-44. PubMed ID: 7536170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.